Trending...
- CryptaBox Introduces a Hardware Crypto Cold Storage Wallet
- UK Financial Ltd Makes History as MayaCat (SMCAT) Becomes the World's First Exchange-Traded ERC-3643 Security Token
- YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
~ Harrisburg, PA - Governor Josh Shapiro is urging health insurers in Pennsylvania to make contraception more accessible and affordable without unnecessary hurdles. This call to action comes after the recent launch of the first ever FDA approved over-the-counter (OTC) daily birth control pill, Opill.
Governor Shapiro has always been a strong advocate for women's access to reproductive healthcare and is now calling on other insurers to follow the lead of major companies CVS Health Plans and Geisinger Health Plans. These two insurers have announced that they will cover OTC contraception with or without a prescription at no cost.
"I am glad to see that CVS Health Plans are joining Geisinger Health Plans to cover Opill without a prescription - and more insurers should follow suit," said Governor Shapiro. "I've always fought to protect and defend access to reproductive healthcare, and my Administration will continue to hold insurers accountable and ensure that women have the personal freedom to make choices over their own bodies."
More on The PennZone
In an effort to encourage other insurers in Pennsylvania to adopt this best practice, Governor Shapiro's Administration has issued guidance for health insurers to cover OTC birth control with or without a prescription. The Pennsylvania Insurance Department (PID) is also asking insurers who choose not to cover OTC contraception options to provide additional information on why they are not complying with federal law and regulations.
"We are glad to see insurers continue to take steps towards a best practice that ensures Pennsylvanians are empowered with choices in their reproductive healthcare," said Pennsylvania Insurance Commissioner Michael Humphreys. "The Shapiro Administration is committed to supporting women's freedom to make their own healthcare decisions and the right to access the full scope of reproductive health care."
Not only does insurance coverage of OTC contraception provide easier access for women, but it can also save them nearly $250 a year. The FDA recently approved Opill (norgestrel) for nonprescription use, making it available for purchase at drug stores, convenience stores, grocery stores, and online without a prescription. This means that individuals will no longer need to see a healthcare provider before obtaining this contraceptive medication.
More on The PennZone
Opill has been classified as a progestin-only pill, which is considered a safer option for individuals with certain medical conditions such as high blood pressure, diabetes, and cardiovascular disease. According to the FDA, when taken correctly, Opill is expected to be the most effective non-prescription contraception method available. This could potentially help reduce the number of unintended pregnancies in Pennsylvania, which currently accounts for almost half of the over six million pregnancies annually in the U.S.
Pennsylvanians who have any insurance related questions or issues can file a complaint with PID's Consumer Services Bureau or by calling 1-877-881-6388.
Governor Shapiro's call for insurers to cover OTC contraception comes at a crucial time when access to reproductive healthcare is being threatened. With this new option available for women in Pennsylvania, it is hoped that other insurers will follow suit and make contraception more accessible and affordable for all.
Governor Shapiro has always been a strong advocate for women's access to reproductive healthcare and is now calling on other insurers to follow the lead of major companies CVS Health Plans and Geisinger Health Plans. These two insurers have announced that they will cover OTC contraception with or without a prescription at no cost.
"I am glad to see that CVS Health Plans are joining Geisinger Health Plans to cover Opill without a prescription - and more insurers should follow suit," said Governor Shapiro. "I've always fought to protect and defend access to reproductive healthcare, and my Administration will continue to hold insurers accountable and ensure that women have the personal freedom to make choices over their own bodies."
More on The PennZone
- Poolvillas Expands Local Presence on the Costa Blanca with New Offices in Moraira and Denia – Over 30 Years of Expertise Now Even Closer to Guests
- Radarsign Redefines Crosswalk Safety with Launch of CrossCommand™ RRFB Crosswalk
- OpenSSL Corporation Opens 2026 Advisory Committees' Elections: Shape the Future!
- Steve Everett Jr. Named President of L.T. Hampel Corporation
- Acuvance Acquires ROI Healthcare Solutions, Building a Dedicated Healthcare ERP Practice
In an effort to encourage other insurers in Pennsylvania to adopt this best practice, Governor Shapiro's Administration has issued guidance for health insurers to cover OTC birth control with or without a prescription. The Pennsylvania Insurance Department (PID) is also asking insurers who choose not to cover OTC contraception options to provide additional information on why they are not complying with federal law and regulations.
"We are glad to see insurers continue to take steps towards a best practice that ensures Pennsylvanians are empowered with choices in their reproductive healthcare," said Pennsylvania Insurance Commissioner Michael Humphreys. "The Shapiro Administration is committed to supporting women's freedom to make their own healthcare decisions and the right to access the full scope of reproductive health care."
Not only does insurance coverage of OTC contraception provide easier access for women, but it can also save them nearly $250 a year. The FDA recently approved Opill (norgestrel) for nonprescription use, making it available for purchase at drug stores, convenience stores, grocery stores, and online without a prescription. This means that individuals will no longer need to see a healthcare provider before obtaining this contraceptive medication.
More on The PennZone
- Max Tucci Award-Winning Media Powerhouse Launches New Podcast —Executive Produced by Emmy-Winning Daytime Icons Suzanne Bass & Fran Brescia Coniglio
- MILBERT.ai Brings Real Time Session Defense to Google Workspace and Google Cloud
- Appliance Outlet Caps Off a Record-Setting 2025 Nationwide, Gears Up for Even Greater Growth in 2026
- Perry County Real Estate Agency Partners with Internet Marketing Company
- Philadelphia HVAC Companies Were Not Created Equal
Opill has been classified as a progestin-only pill, which is considered a safer option for individuals with certain medical conditions such as high blood pressure, diabetes, and cardiovascular disease. According to the FDA, when taken correctly, Opill is expected to be the most effective non-prescription contraception method available. This could potentially help reduce the number of unintended pregnancies in Pennsylvania, which currently accounts for almost half of the over six million pregnancies annually in the U.S.
Pennsylvanians who have any insurance related questions or issues can file a complaint with PID's Consumer Services Bureau or by calling 1-877-881-6388.
Governor Shapiro's call for insurers to cover OTC contraception comes at a crucial time when access to reproductive healthcare is being threatened. With this new option available for women in Pennsylvania, it is hoped that other insurers will follow suit and make contraception more accessible and affordable for all.
0 Comments
Latest on The PennZone
- A High-Velocity Growth Story Emerges in Marine and Luxury Markets
- $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway
- Peernovation 365 is Now Available
- Snap-a-Box Brings Texas' First Robot-Cooked Chinese Takeout to Katy–Fulshear
- UK Financial Ltd Makes History as MayaCat (SMCAT) Becomes the World's First Exchange-Traded ERC-3643 Security Token
- SNS Research Launches SNS Market Intelligence Platform for visual market intelligence for pharma
- Narcissist Apocalypse Marks 7 Years as a Leading Narcissistic Abuse Podcast
- High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
- CryptaBox Introduces a Hardware Crypto Cold Storage Wallet
- YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
- High-End Exterior House Painting in Boulder, Colorado
- Simpson and Reed Co-Founders Shardé Simpson, Esq. and Ciara Reed, Esq. Launch "Hello Wilma,"
- Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
- Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
- Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
- New Year, New Home: Begin 2026 at Heritage at South Brunswick
- Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
- Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025
- CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve
- ASR Media, Social T Marketing & PR Announce Merger